Protocol 9766-CL-0111 - A Non-Interventional Registry Study of Systemic Antifungal Therapy in Adult Subjects with Invasive Mucormycosis or Invasive Aspergillosis Caused by a Non-fumigatus Species Protocol for Phase 4 Study of ASP9766

Project: Research project

StatusActive
Effective start/end date4/7/174/7/20

Funding

  • inVentiv Health Clinical (Protocol 9766-CL-0111)
  • Astellas Pharma Global Development, Inc. (Protocol 9766-CL-0111)